reference/24364673

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24364673

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	4114
issn	1558-8238 0021-9738
issueIdentifier	9
pageRange	4098-4114
publicationName	The Journal of clinical investigation
startingPage	4098
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_198be1621a05a7b6382d2ec966c36982
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_70bf1a9a612723638cf7d65578afb849 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0f2202eae90981096fb4e2084b02e597 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e6992ac9e02d818557ae10af83c7dedc
bibliographicCitation	Song KH, Kim JH, Lee YH, Bae HC, Lee HJ, Woo SR, Oh SJ, Lee KM, Yee C, Kim BW, Cho H, Chung EJ, Chung JY, Hewitt SM, Chung TW, Ha KT, Bae YK, Mao CP, Yang A, Wu TC, Kim TW. Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance. J Clin Invest. 2018 Aug 31;128(9):4098–114. PMID: 30124467; PMCID: PMC6118592.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40658c82462c4996d0ce4da5d2fa17cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5041-5982 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8e2d6376f78cfa28f22ab98d95738b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9ff0550187c18d52fa04d3d5aae469d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0aa5affa0157127b90c589afd3f49c71 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_169464242c88b5b8635db907235412fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0e003e98f791e877298bc6cbfd6a69c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6476675896c4b6c9e75dc6f50ea1f60 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6177-1648 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5378-9258 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bde566607d59ab4fdd53030572a322e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e887a3c0a34ce2f27b55c015f20431dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5243-5020 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_977abf0f66074e8546380214d28be231 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_179a967ca92555dda5cb18b7ee3a8697 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c59d8e883eac21a7f061f2853291f1d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7964-3540 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_109a4ba52bd2ea257acb64080c3732dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62aac7a8c66c886cc618f635f69b6716 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0fabc2077b96a0fc6df300f50c47708 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28f9b718e903fe53c643716a55431567 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ccb37112c47143d540d1c21cd34a7c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91ec65b00ae86929da85e217243382e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51e54ec64bb9abab84f0f602916b7054
date	2018-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/30124467 https://pubmed.ncbi.nlm.nih.gov/PMC6118592 https://doi.org/10.1172/jci96804
isPartOf	https://portal.issn.org/resource/ISSN/1558-8238 https://portal.issn.org/resource/ISSN/0021-9738 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4632
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
discusses	http://id.nlm.nih.gov/mesh/M000601269 http://id.nlm.nih.gov/mesh/M0001491 http://id.nlm.nih.gov/mesh/M0404124 http://id.nlm.nih.gov/mesh/M000644122 http://id.nlm.nih.gov/mesh/M0374090 http://id.nlm.nih.gov/mesh/M0000348
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000226Q000172 http://id.nlm.nih.gov/mesh/D025261Q000172 http://id.nlm.nih.gov/mesh/D009369Q000378 http://id.nlm.nih.gov/mesh/D009369Q000628 http://id.nlm.nih.gov/mesh/D008928Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D007167 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D025261Q000235 http://id.nlm.nih.gov/mesh/D000226Q000235 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D044127 http://id.nlm.nih.gov/mesh/D011836 http://id.nlm.nih.gov/mesh/D009369Q000235 http://id.nlm.nih.gov/mesh/D016513 http://id.nlm.nih.gov/mesh/D051795Q000378 http://id.nlm.nih.gov/mesh/D016688 http://id.nlm.nih.gov/mesh/D000975Q000008 http://id.nlm.nih.gov/mesh/D019139
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4ecbd6756e791a9a178feda0ca94122f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_649704210001336d72097d025d61e716 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.6.3.14 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d4cb671d20806caaf5644afb03f6746 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10476 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID71679

Total number of triples: 89.